This Healthcare Giant Had 12 Products That Generated Double-Digit Growth Last Quarter and There's Still Many More in the PipelineThe Motley Fool • 08/17/24
Amgen's Mixed Q2 Results Highlight Obesity Drug Potential, Analysts Focus Shifts To Upcoming Clinical ReadoutsBenzinga • 08/07/24
Amgen Is Redoubling Its Efforts To Take On Weight-Loss Kingpins Novo, LillyInvestors Business Daily • 08/06/24
Amgen Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallBenzinga • 08/06/24
Dow Jones Biotech Amgen, MercadoLibre, Ferrari Hold Up In Shaken MarketInvestors Business Daily • 08/05/24
Exploring Analyst Estimates for Amgen (AMGN) Q2 Earnings, Beyond Revenue and EPSZacks Investment Research • 08/01/24